XOMA (XOMAP) News Today $25.51 +0.13 (+0.51%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period May 14, 2024 | markets.businessinsider.comBuy Rating Affirmed for Xoma with Enhanced Price Target Reflecting New Royalty Assets and Growth ProspectsApril 30, 2024 | msn.comLeerink Partners Initiates Coverage of XOMA (XOMA) with Outperform RecommendationApril 17, 2024 | thestreet.comXOMA Corporation 8.625% Series A Cumulative Perpetual Preferred StockMarch 21, 2024 | msn.comXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendMarch 13, 2024 | finanznachrichten.deAdhoc: Kuros Biosciences AG: Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023March 11, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Xoma (XOMA) and Lexicon Pharmaceuticals (LXRX)February 23, 2024 | msn.comCox Communications wins order overturning $1 billion US copyright verdictFebruary 17, 2024 | finance.yahoo.comXOMA Jun 2024 20.000 putFebruary 17, 2024 | finance.yahoo.comXOMA Sep 2024 12.500 putFebruary 16, 2024 | markets.businessinsider.comStrategic Acquisitions and Royalty Income Streams Justify Buy Rating for XomaFebruary 16, 2024 | marketwatch.comKinnate Biopharma Shares Rise on XOMA AcquisitionFebruary 16, 2024 | markets.businessinsider.comKinnate Biopharma To Be Acquired By XOMA In Cash Deal; Stock GainsFebruary 16, 2024 | marketbeat.comTrading was temporarily halted for "XOMAP" at 07:02 AM with a stated reason of "News pending."January 18, 2024 | finanznachrichten.deXOMA Corporation: XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA AcquisitionJanuary 18, 2024 | finance.yahoo.comXOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® AcquisitionJanuary 18, 2024 | finance.yahoo.comXOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® AcquisitionJanuary 8, 2024 | marketwatch.comXOMA Names Hughes Permanent CEO; Wyszomierski Becomes ChairmanJanuary 8, 2024 | finance.yahoo.comXOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of DirectorsDecember 22, 2023 | benzinga.comXOMA Stock (NASDAQ:XOMA) Dividends: History, Yield and DatesNovember 11, 2023 | morningstar.comXOMA Corp XOMANovember 7, 2023 | msn.comXOMA GAAP EPS of -$0.60 misses by $0.12, revenue of $0.83M misses by $0.36MOctober 27, 2023 | finanznachrichten.deObsEva SA: Organon Returns Ebopiprant to XOMAOctober 27, 2023 | finance.yahoo.comOrganon Returns Ebopiprant to XOMASeptember 18, 2023 | msn.comXoma (XOMA) Moves 7.7% Higher: Will This Strength Last?September 15, 2023 | money.usnews.comXOMA CorpSeptember 13, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Their Buy Rating for Xoma (XOMA)August 13, 2023 | finance.yahoo.comOwning 35% shares,institutional owners seem interested in XOMA Corporation (NASDAQ:XOMA),August 8, 2023 | finance.yahoo.comXOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMAP and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia’s Quiet $1 Trillion Pivot (Ad)Nvidia recently added $277 billion in market cap … IN ONE DAY. Find out details on these three critical Nvidia partners immediately. XOMAP Media Mentions By Week XOMAP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMAP News Sentiment▼0.440.62▲Average Medical News Sentiment XOMAP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMAP Articles This Week▼20▲XOMAP Articles Average Week Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMAP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alpha Tau Medical News BriaCell Therapeutics News eFFECTOR Therapeutics News Fortress Biotech News GeoVax Labs News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMAP) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.